Dual Sphere Icon
Dr Richa Goyal

Dr Richa Goyal

CEO & Founder, Dual Sphere Consulting

The Mandate

"I started Dual Sphere because senior expertise in HEOR should not require a client to navigate a 300-person firm to access it. After two decades working inside some of the largest organisations in this industry - building models, writing dossiers, advising on submissions - I know exactly where value is created in this work and where it isn't. At Dual Sphere, the person with the deepest relevant experience is involved in your project directly, from the first conversation to the final deliverable."

20 years · IQVIA · Parexel · TCS · Capita · ISPOR India President-Elect

Scientific Philosophy

Good HEOR is not about producing documents. It is about understanding what a specific payer body will accept, why, and how to structure the evidence to reach that outcome. That requires someone who has read the guidance, attended the conferences, and engaged with the scientific committees - not someone who has read about them.

Professional Roles

ISPOR India Chapter - President-Elect (ISPOR is the International Society for Pharmacoeconomics and Outcomes Research) - the primary global professional and scientific society for this field. (President-Elect is a peer-elected position.)

Therapeutic Areas

OncologyRare DiseaseCardiovascularInfectious DiseaseCNSImmunologyRespiratory

Geographic Expertise

APAC (Singapore, Australia, Thailand, India)USAUKEuropeCanadaGlobal multi-country HTA strategy

Career Trajectory

Dual Sphere Consulting

Founded 2025. Operates from Singapore, UK and India with Global client engagements.

IQVIA

Senior consulting and leadership in HEOR, real-world evidence, and global market access.

TCS (Tata Consultancy Services)

HEOR and RWE delivery across global pharma clients.

Capita

Early career foundation in health economics and outcomes research.

Heron (Parexel)

Market access consulting and HTA submission support.

The Team

The Dual Sphere team brings together health economists, systematic reviewers, medical writers, and market access strategists. Every team member has life sciences or academic HEOR backgrounds - not general consulting backgrounds.

Dr Henna Khan

Associate Director

Dr Henna Khan

Systematic literature reviews, meta-analyses, and evidence synthesis. Specialisation in oncology and rare disease evidence packages.

Venkata Sharmila Uribandi

Associate Director

Venkata Sharmila Uribandi

Medical communications and value dossier development. Experience in translating complex clinical and economic evidence for payer audiences.

Ravikishore

Associate Director

Ravikishore

Real-world evidence study design and execution. Database analysis and retrospective cohort study methodology.

Dr Akanksha Verma

Senior Consultant

Dr Akanksha Verma

Health economic modelling and RWE strategy. Background in pharmacoeconomic model development and evidence synthesis for global HTA submissions.

Execution Team

Dr Anjali V Joseph

Consultant

Dr Anjali V Joseph

Abhilash

Consultant

Abhilash

Dr. Saba Abidi

Senior Analyst

Dr. Saba Abidi

Vaisshnavi Goel

Analyst

Vaisshnavi Goel

Dr Aishwarya Naruboina

Analyst

Dr Aishwarya Naruboina

Dr Mounika Musalreddygari

Analyst

Dr Mounika Musalreddygari

Mrs. Pratiksha Sumit Bulkunde

Analyst

Mrs. Pratiksha Sumit Bulkunde

Leadership In Action

Dr. Richa Goyal speaking at IIT Banaras
GEETANJALI UNIVERSITY
Dr. Richa Goyal networking at Galgotia College of Pharmacy
Dual Sphere Consulting team panel
Dr. Richa Goyal speaking at HEoRizon
IIPH2
Dr. Richa Goyal networking at Chandigarh univrsity

Working on a submission, a model, or a strategy?
Let's talk

We take on a focused number of engagements at any time to ensure senior-level attention on every project.

Start a conversation